Psychedelic Medicine [Two Volumes]

Book flyer
MS Word
International
MS Word

Psychedelic Medicine [Two Volumes] New Evidence for Hallucinogenic Substances as Treatments

Michael J. Winkelman, ed., Thomas B. Roberts, ed.

ISBN: 0-275-99023-0

ISBN-13: 978-0-275-99023-7

DOI:

728 pages

Praeger Publishers

Publication: 6/30/2007

List Price: $200.00 (UK Sterling Price: £137.95)

Discount Price: $100.00 Sale Price for U.S. Customers Only. Save 50%. Ends 12/31/2009.

Availability:

Media Type: Hardcover

Trim Size: 6 1/8 x 9 1/4

Subjects:

Reviews:

Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments....in two volumes, brings together much of the contemporary knowledge related to hallucinogens in a way that it will appeal to the scientific community, and will contribute to the increasing interest that is being paid to this group of drugs....These weighty tomes, of well over 750 pages between them are clearly very well presented. The layout is clear, the syntax is formal and accomplished, the chapters are extensively referenced, and the index is detailed.
—Journal of Psychiatric and Mental Health Nursing 2008
[T]his extensive two-volume tome currently serves as ^Ithe^R authoritative reference text on psychedelic medicines, particularly with regard to the advances made in the last ten years....No corners have been cut with the essays either, each of which have been written specifically for this book and, collectively, they offer a comprehensive range of insights to this anthology. Although almost wholly positive, this treatise on the possible benefits of psychedelic agents in the treatment of psychological disease still offers a reasoned and balanced approach....^IPsychedelic Medicine^R has a great deal of timely information to offer physical and mental health professionals and students, as well as all those working in recreational drug research, policy, treatment and intervention, whether involved with psychedelics or not.
—Drugs and Alcoholism Today June 2008
This is one of the few recent books that treat this subject in a scholarly way and is recommended for all medical and academic libraries. Public libraries should also purchase it because such material is scarce in other books.
—Library Journal 11/15/2007
When hallucinogenic drugs are mentioned, one is more likely to think of drugs of abuse, mind-altering drugs, or drugs subject to governmental regulation than of drugs that may have a therapeutic application. For this reason, this two-volume treatise serves a useful purpose not only in providing an update on the limited number of hallucinogenic drugs that already have some therapeutic application (based on relatively limited research), but also by covering the history of these mind-altering drugs and the cultural, social, political, legal, economic, and ethical factors that have encumbered research on these compounds. The work is well organized, with chapters written by medical and legal professionals active in the field.... Highly recommended. Lower-level undergraduates and above; general readers.
—Choice 1/1/2008
[W]e are in the second stage of a three-stage process of psychedelic re-evolution. The first stage ended in demonization, now we are in the reconceptualization phase, and eventually will move to the integration stage. Psychedelics have reached middle age, as have my fellow baby boomers. It is up to us, with the help of scholarly research and publications like these volumes, to educate society about the value of psychedelics.
—The Erowid Review July 14, 2008

Description: Psychedelic substances present in nature have been used by humans across hundreds of years to produce mind-altering changes in thought, mood, and perception—changes we do not experience otherwise except rarely in dreams, religious exaltation, or psychosis. U.S. scientists were studying the practical and therapeutic uses for hallucinogens, including LSD and mescaline, in the 1950s and 1960s supplied by large manufacturers including Sandoz. But the government took steps to ban all human consumption of hallucinogens, and thus the research. By the 1970s, all human testing was stopped. Medical concerns were not the issue, the ban was motivated by social concerns, not the least of which were created by legendary researcher Timothy Leary, a psychologist who advocated free use of hallucinogens by all who desired. Nationwide, however, a cadre of scholars and researchers has persisted in pushing the federal government to again allow human testing and the moratorium has been lifted. The FDA has begun approving hallucinogenic research using human subjects. In these groundbreaking volumes, top researchers explain the testing and research underway to use—under the guidance of a trained provider—psychedelic substances for better physical and mental health.

Table of Contents:

Volume I: Psychedelic Medicine: Social, Clinical and Legal Perspectives
Preface
Editors Overview of Psychedelic Medicine
Section I: The Social and Clinical Context
Chapter 1: Introduction: Therapeutic Bases of Psychedelic Medicines: Psychointegrative Effects
Chapter 2: The Healing Vine: Ayahuasca as Medicine in the 21st Century
Chapter 3: Contemporary Psychedelic Therapy: An Overview
Chapter 4: Therapeutic Guidelines: Dangers and Contra-Indications in Therapeutic Applications of Hallucinogens
Section II: Medical Applications
Chapter 5: Response Of Cluster Headaches to Psilocybin and LSD,
Chapter 6: Psilocybin Treatment of Obsessive-Compulsive Disorder
Chapter 7: Therapeutic Uses of MDMA
Chapter 8: MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder
Chapter 9: Psychedelic Drugs for the Treatment of Depression
Chapter 10: Marijuana and AIDS
Chapter 11: The Use of Psilocybin in Patients with Advanced Cancer and Existential Anxiety
Section III: Legal Aspects of the Medical Use
Chapter 12: Psychedelic Medicine and the Law
Chapter 13: The Legal Bases for Religious Peyote Use
Chapter 14: The Supreme Courts Psychedelic Case
Chapter 15: Conclusions
About the Contributors
Volume 2: Psychedelic Medicine: Addictions Medicine and Transpersonal Healing
Preface
Chapter 1: Introduction
Section I: Treating Substance Abuse
Chapter 2: Hallucinogens in the Treatment of Alcoholism and Other Addictions
Chapter 3: Addiction, Despair, and the Soul: Psychedelic Psychotherapy
Chapter 4: The Therapeutic Use of Peyote in the Native American Church
Chapter 5: Ibogaine and Substance Abuse Rehabilitation
Chapter 6: Ketamine Psychedelic Psychotherapy
Chapter 7: Ayahuasca Treatment of Cocaine-Paste Addiction
Section II: Guidelines for Psychotherapeutic Applications
Chapter 8: The Ten Lessons of Psychedelic Psychotherapy, Rediscovered
Chapter 9: Therapeutic Guidelines from Shamanic Traditions
Chapter 10: Common Processes in Psychedelic-Induced Psychospiritual Change
Chapter 11: Preliminary Remarks on Interpreting Resistance to Psychedelic Insights
Section III: Transpersonal Dimension of Healing with Psychedelic Medicines
Chapter 12: Psychedelics in Psychological Health and Growth
Chapter 13: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
Chapter 14: Remarkable Healing During Psychedelic Psychotherapy
Chapter 15: Transpersonal Healing with Hallucinogens
Chapter 16: Conclusions and Recommendations: The Wider Contexts
About the Contributors

About the Author: Michael J. Winkelman is former Head of Sociocultural Anthropology and current Associate Professor in the School of Human Evolution and Social Change at Arizona State University. He has served as President of the Anthropology of Consciousness section of the American Anthropological Association and was founding President of its Anthropology of Religion section. His Ph.D. was completed at the University of California, Irvine and his Post-Doctoral Fellowship at the National Institute on Drug Abuse. He has researched shamanism across 30 years. His book, Shamanism (2000) was reviewed as brilliant.

Thomas B. Roberts is Professor Emeritus of Educational Psychology in the Department of Leadership, Educational Psychology and Foundations at Northern Illinois University. He is a Founding Member of MAPS, the Multidisciplinary Association for Psychedelic Studies. As part of his retirement activities, he spent the fall of 2006 as a Visiting Scientist at the Johns Hopkins University Department of Psychiatry and Human Sciences' Behavioral Biology Research Center, chairing a weekly staff development discussion about psychedelics. He has taught Foundations of Psychedelic Studies, now an Honors Program Seminar, at NIU since 1982. Roberts' Ph.D. in Educational Administration and Psychology is from Stanford University.

LCC Class: RM315

PDF Catalogs:
Psychology Catalog 2008.pdf	Praeger Health and Wellness Spring 2008.pdf
Praeger Perspectives 2008.pdf


All rights reserved. Copyright © 1999-2009 ABC-CLIO 130 Cremona Dr., Santa Barbara, CA 93117, 805-968-1911